Evidence map›Paper›PMID 35316572›Full record

Trial reportJournal of cachexia, sarcopenia and muscle2022

Pectoralis major muscle atrophy is associated with mitochondrial energy wasting in cachectic patients with gastrointestinal cancer.

Adeline Dolly, Thierry Lecomte, Nicolas Tabchouri, Morgane Caulet, Nicolas Michot, Benjamin Anon, Romain Chautard, Yoann Desvignes, Mehdi Ouaissi, Gaëlle Fromont-Hankard and 2 more

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in Journal of cachexia, sarcopenia and muscle, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02573974 (Study of Alterations in Skeletal Muscle Energy Metabolism in Undernourished Patients With Gastrointestinal Cancer), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02573974 nacompletednot on this map

Study of Alterations in Skeletal Muscle Energy Metabolism in Undernourished Patients With Gastrointestinal Cancer

TypeinterventionalSponsorUniversity Hospital, ToursRan2016 to 2018Enrolled51ConditionsUndernutrition, Gastrointestinal CancerArmsSamples
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Adeline DollyUniversité de Tours, Inserm UMR1069, Nutrition, Croissance et Cancer, Tours, France.ORCID 0000-0002-6878-0168
Thierry LecomteUniversité de Tours, Inserm UMR1069, Nutrition, Croissance et Cancer, Tours, France.ORCID 0000-0001-5093-0212
Nicolas TabchouriDepartment of Digestive, Oncological, Endocrine, Hepato-Biliary, Pancreatic and Liver Transplant Surgery, University Hospital of Tours, Tours, France.
Morgane CauletDepartment of hepatogastroenterology and digestive oncology, University Hospital of Tours, Tours, France.
Nicolas MichotDepartment of Digestive, Oncological, Endocrine, Hepato-Biliary, Pancreatic and Liver Transplant Surgery, University Hospital of Tours, Tours, France.
Benjamin AnonDepartment of hepatogastroenterology and digestive oncology, University Hospital of Tours, Tours, France.
Romain ChautardDepartment of hepatogastroenterology and digestive oncology, University Hospital of Tours, Tours, France.
Yoann DesvignesDelegation for Clinical Research and Innovation (DRCI), University Hospital of Tours, Tours, France.
Mehdi OuaissiDepartment of Digestive, Oncological, Endocrine, Hepato-Biliary, Pancreatic and Liver Transplant Surgery, University Hospital of Tours, Tours, France.
Gaëlle Fromont-HankardUniversité de Tours, Inserm UMR1069, Nutrition, Croissance et Cancer, Tours, France.ORCID 0000-0002-7730-2264
Jean-François DumasUniversité de Tours, Inserm UMR1069, Nutrition, Croissance et Cancer, Tours, France.ORCID 0000-0002-2293-6606
Stéphane ServaisUniversité de Tours, Inserm UMR1069, Nutrition, Croissance et Cancer, Tours, France.ORCID 0000-0002-3127-9679
Université de Tours · FR

Funding

Canceropole Grand OuestFrench Ministry of Higher Education, Research and InnovationFrench Society of Clinical Nutrition and MetabolismInstitut National du CancerLigue Nationale Contre le Cancer
6 · The paper itself

Abstract

backgroundCancer cachexia is a multifactorial syndrome characterized by involuntary and pathological weight loss, mainly due to skeletal muscle wasting, resulting in a decrease in patients' quality of life, response to cancer treatments, and survival. Our objective was to investigate skeletal muscle alterations in cachectic cancer patients.

methodsThis is a prospective study of patients managed for pancreatic or colorectal cancer with an indication for systemic chemotherapy (METERMUCADIG - NCT02573974). One lumbar CT image was used to determine body composition. Patients were divided into three groups [8 noncachectic (NC), 18 with mild cachexia (MC), and 19 with severe cachexia (SC)] based on the severity of weight loss and muscle mass. For each patient, a pectoralis major muscle biopsy was collected at the time of implantable chamber placement. We used high-resolution oxygraphy to measure mitochondrial muscle oxygen consumption on permeabilized muscle fibres. We also performed optical and electron microscopy analyses, as well as gene and protein expression analyses.

resultsForty-five patients were included. Patients were 67% male, aged 67 years (interquartile range, 59-77). Twenty-three (51%) and 22 (49%) patients were managed for pancreatic and colorectal cancer, respectively. Our results show a positive correlation between median myofibres area and skeletal muscle index (P = 0.0007). Cancer cachexia was associated with a decrease in MAFbx protein expression (P < 0.01), a marker of proteolysis through the ubiquitin-proteasome pathway. Mitochondrial oxygen consumption related to energy wasting was significantly increased (SC vs. NC, P = 0.028) and mitochondrial area tended to increase (SC vs. MC, P = 0.056) in SC patients. On the contrary, mitochondria content and networks remain unaltered in cachectic cancer patients. Finally, our results show no dysfunction in lipid storage and endoplasmic reticulum homeostasis.

conclusionsThis clinical protocol brings unique data that provide new insight to mechanisms underlying muscle wasting in cancer cachexia. We report for the first time an increase in mitochondrial energy wasting in the skeletal muscle of severe cachectic cancer patients. Additional clinical studies are essential to further the exploring and understanding of these alterations.

Indexed as

Colorectal NeoplasmsGastrointestinal NeoplasmsAgedCachexiaFemaleHumansMaleMiddle AgedMitochondriaMuscular AtrophyPectoralis MusclesProspective StudiesQuality of LifeWeight LossCancer cachexiaClinical studyMitochondrial bioenergeticsMyosteatosisPectoralis majorProteolysis

Identifiers

PMID35316572
PMCPMC9178397
OpenAlexW4220889554

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.